Stock TENX TENAX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Tenax Therapeutics, Inc.

Equities

TENX

US88032L6056

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
3.56 USD +1.71% Intraday chart for Tenax Therapeutics, Inc. -0.84% -83.79%
Mar. 28 Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 28 Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Tenax Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ec07bb77ffac69e61b4.slKqT2ccILaeDjPwGthsH4cxyT1A3cAhutQOgjJ6WlI.4X_1K1MuQoLaelzHS40mRbVAinIV6rhC7YtR-GEZaWL9Bt55Ul1T1_Z-QA~94656a63fa2be3a36f19fdf69400301a

Analyst Recommendations on Tenax Therapeutics, Inc.

Roth MKM Initiates Coverage on Tenax Therapeutics With Buy Rating, $6 Price Target MT
Traders Digest Jobless Claims Data After Fed Rate Hike, Prompting Mixed Premarket Trading for US Equity Futures MT
TENAX THERAPEUTICS : HC Wainwright Starts Tenax Therapeutics at Buy With $5 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.56 USD
Average target price
32.5 USD
Spread / Average Target
+812.92%
High Price Target
35 USD
Spread / Highest target
+883.15%
Low Price Target
30 USD
Spread / Lowest Target
+742.70%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Tenax Therapeutics, Inc.

Roth MKM

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. TENX Stock
  4. Consensus Tenax Therapeutics, Inc.